Status:
NOT_YET_RECRUITING
A Clinical Study of Bacillus Coagulans in Acute Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation
Lead Sponsor:
Yamin Fan
Conditions:
Acute Graft-versus-host Disease
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
To evaluate the preventive effect of Bacillus coagulans on acute graft-versus-host disease (aGVHD) after hematopoietic stem cell transplantation
Detailed Description
The study is conducted on patients after hematopoietic stem cell transplantation and the intervention is Bacillus coagulans, aiming to investigate the preventive effect of Bacillus coagulans on acute ...
Eligibility Criteria
Inclusion
- Patients are fully aware of the study, voluntarily participate and sign informed consent;
- Age: ≥18 years old;
- Patients with hematologic malignancies undergoing allo-HSCT and patients with severe aplastic anemia (SAA) undergoing allo-HSCT were treated with myeloablative conditioning (MAC).
Exclusion
- Refused to participate in this clinical study;
- Unable to take the drug orally;
- Allergic to Bacillus coagulans;
- People take allo-HSCT with reduced intensity conditioning (RIC) and nonmyeloablative conditioning (NMC);lymphoma or multiple myeloma with auto-HSCT; multiple myeloma patients.
Key Trial Info
Start Date :
September 27 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 30 2026
Estimated Enrollment :
286 Patients enrolled
Trial Details
Trial ID
NCT06593834
Start Date
September 27 2024
End Date
April 30 2026
Last Update
September 25 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.